A global reemergence of human enterovirus 68 (EV-D68) associated with severe respiratory illness occurred in 2014. We developed and validated an EV-D68-specific real-time reverse transcription-PCR (RT-PCR) for the detection of EV-D68 in respiratory samples. The rapid diagnosis of EV-D68 may contribute to better management of EV-D68 infections.
pathogen RT mix, 100 nM primers and probe (0.03 l of stock 80 M), 2.5 l of 10ϫ internal control RNA, 2.5 l of 10ϫ internal control assay, 0.50 l of High-ROX dye solution, and RNase-free water to adjust the volume to 25 l. The cycling conditions for the amplification were as follows: reverse transcription at 50°C for 20 min, an initial PCR activation step at 95°C for 5 min, and 45 cycles of two-step cycling for 10 s at 95°C and for 30 s at 60°C.
A linearity study was performed on serial 10-fold dilutions of quantified plasmid DNA in RT-PCR-grade water (Ambion, Austin, TX). A linear correlation between the log starting copy number and cycle threshold (C T ) was achieved with 8.0 to 0.1 log 10 DNA plasmid copies/l (Fig. 1A) . At each concentration, four replicates were tested in a single run. Liner regression analysis of the C T values against the log 10 EV-D68 plasmid concentration resulted in an R 2 value of 0.9886 (Fig. 1A) . The precision of the assay, defined as the coefficient of variation (CV), was measured using the linearity test results and the average intra-assay CV value, 2.7% Ϯ 1.4% (Fig. 1A) , while the average interassay variability was 2.9% Ϯ 0.9% (data not shown). The analytical sensitivity of the assay was assessed by determining the lower limit of detection (LOD) using a dilution series of standard DNA plasmids at the following concentrations: 1, 10, 25, 50, 100, and 500 copies/reaction. From each dilution, 10 replicates were tested in 3 different assays on different days. The proportion of the positive results obtained from each input concentration was analyzed using probit regression analysis. The probit analysis showed a 95% LOD of 13 copies/reaction corresponding to 715 copies/ml in bronchoalveolar lavage fluid and 286 copies/ml in nasal swab (Fig. 1B ) samples for our current extraction protocol (EZ1 system; Qiagen, Hilden, Germany).
To assess the effects of nucleic acid extraction and the sample matrix, three aliquots of DNA plasmids containing 6.0 (mean C T value, 20.6), 4.0 (27.9), and 2.0 (34.5) log 10 DNA plasmid copies/l were added to nasal swabs negative for EV-D68 before the extraction. The samples were extracted using the EZ1 system (Qiagen, Hilden, Germany) with the EZ1 virus minikit v2.0 (Qiagen, Hilden, Germany) and subsequently amplified with the EV-D68 real-time RT-PCR. The average C T difference between the obtained results and the DNA plasmid quantity was 1.0 Ϯ 0.4.
The specificity of the EV-D68 real-time RT-PCR was evaluated by testing a set of reference strains (25 HEV, 2 parechovirus, and 4 HRV), 10 HEV isolates, and 25 positive respiratory samples containing 17 different HEV genotypes. Finally, 56 HRV-positive samples containing HRV strains belonging to species A, B, or C (as previously determined by VP4/VP2 gene sequencing) were also tested. None of the reference strains, HEV isolates, or HEV-positive or HRV-positive samples produced a detectable signal. Finally, the inclusivity of the EV-D68 real-time RT-PCR was assessed by testing a series of 21 sequencing-confirmed EV-D68-positive samples (4) . All positive EV-D68 samples were correctly detected with a median C T value of 25.5 (range, 18.4 to 31.4).
This new real-time RT-PCR is a useful tool for detecting EV-D68 in respiratory samples. The rapid diagnosis of EV-D68 may contribute to better management of EV-D68 infections.
